BTLA/HVEM Axis Induces NK Cell Immunosuppression and Poor Outcome in Chronic Lymphocytic Leukemia.

Interestingly, patients with stable disease (stable CLL) presented lower levels of sBTLA than those who progressed and required therapeutic intervention (progressive CLL), although it did not reach statistical significance ( Figure 4 B).

also in 111,027 other papers